Company: HURA
Filing Date: 2025-11-03
Form Type: S-3
Source: 0001193125-25-262843
Chunk: 66

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-11-03
Form: S-3
Chunk 66
---
 quarterly disbursements of counsel to the Sales Agent up to $5,000 per due diligence update session conducted in connection with each date we file our Annual Report on Form 10-K and $3,500 per due
diligence update session conducted in connection with each date we file a Quarterly Report on Form 10-Q. We will report at least quarterly the number of shares of our Common Stock sold through the Sales Agent under the Sales Agreement, the net
proceeds to us and the compensation paid by us to the Sales Agent in connection with the sales of shares of our Common Stock.

In
connection with the sales of shares of our Common Stock on our behalf, the Sales Agent will be deemed to be an “underwriter” within the meaning of the Securities Act, and the compensation paid to the Sales Agent will be deemed to be
underwriting commissions or discounts. We have agreed in the Sales Agreement to provide indemnification and contribution to the Sales Agent with respect to certain liabilities, including liabilities under the Securities Act.

S-11

The offering of shares of our Common Stock pursuant to this prospectus supplement will
terminate upon the earlier of the sale of all of the shares of our Common Stock provided for in this prospectus supplement or termination of the Sales Agreement as permitted therein.

To the extent required by Regulation M, the Sales Agent will not engage in any market making activities involving our Common Stock while the
offering is ongoing under this prospectus supplement.

The Sales Agent and certain of its respective affiliates may in the future engage
in investment banking and other commercial dealings in the ordinary course of business with us or our affiliates. The Sales Agent and its affiliates may in the future receive customary fees and expenses for these transactions. In addition, in the
ordinary course of its various business activities, the Sales Agent and its respective affiliates may make or hold a broad array of investments and actively trade debt and equity securities (or related derivative securities) and financial
instruments (which may include bank loans) for its own account and for the accounts of its customers. Such investments and securities activities may involve securities and/or instruments of ours or our affiliates. The Sales Agent or its affiliates
may also make investment recommendations and/or publish or express independent research views in respect of such securities or financial instruments and may hold, or recommend to clients that they acquire, long and/or short positions in such
securities and instruments.

This prospectus supplement and the accompanying base prospectus may be made available in electronic format on
a website maintained by the Sales